Team Member Name
Team Member Name
Meet the Team
President
Priya Jaisinghani, MD
Dr. Priya Jaisinghani is an endocrinologist and certified obesity medicine specialist. She is a Clinical Assistant Professor at NYU Grossman School of Medicine. Dr. Jaisinghani received a distinction in service to the community through her work at the The Boggs Center at Rutgers Robert Wood Johnson Medical School, where she also completed her internal medicine residency and was inducted into the AOA Honor Society. She completed her endocrinology training at New York Presbyterian Weill Cornell. She is passionate about minority health, medical education, and mentorship.
Vice President
Devika Umashanker, MD
Devika Umashanker, MD, MS, MBS, DABOM is the Medical Director of Obesity Medicine at Hartford Healthcare Medical Group. She is an Assistant Professor of Clinical Medicine at University of Connecticut School of Medicine and an Assistant Professor at Frank Netter School of Medicine, Quinnipiac University. Dr. Umashanker specializes in the care of patients with obesity and bariatric medicine.
Interim Treasurer
Beverly Tchang, MD, FTOS, DABOM
Dr. Tchang earned her medical degree from SUNY Downstate Medical Center. Dr. Tchang graduated with her BA from University of Chicago and was a NIH T32 trainee. She completed her residency at NewYork-Presbyterian/Weill Cornell , Endocrinology Diabetes & Metabolism Fellowship at NewYork-Presbyterian/Columbia University Irving Medical Center, and Obesity Fellowship at NewYork-Presbyterian/Weill Cornell .
Committee Chairs
Chair of Metabolic/Bariatric Innovation
Kartik Sampath, MD
Dr. Kartik Sampath is an Assistant Professor of Medicine at Weill Cornell Medical Center and an Attending Physician at the New York Presbyterian Hospital/Weill Cornell Medical Center. He is an advanced fellowship trained interventional gastroenterologist.
Dr. Sampath graduated from Carleton College and received his medical degree from RUSH Medical College. He completed his internal medicine residency, gastroenterology fellowship and therapeutic endoscopy fellowship at the Dartmouth-Hitchcock Medical Center. His clinical and research interests relate to the fields of surgical endoscopy, bariatric endoscopy and obesity medicine. He strives to provide effective clinical care within a multi-disciplinary care model, while continuing to develop novel and innovative strategies to manage clinical obesity.
Chair of Community Relations
Natalie Mora, MD
Originally from San Antonio, Texas, Dr.Mora received her BA in Psychology from Georgetown University and MD from the State University of New York (SUNY) Upstate Medical University.
She completed internal medicine residency at the University of Virginia and endocrinology fellowship at the National Institutes of Health (NIH). Dr.Mora is medical director of the Comprehensive Weight Management Program at Nuvance Health in Fairfield County, Connecticut.
She oversees multidisciplinary teams to deliver innovative, tailored treatment plans that integrate medical, nutritional, behavioral, and pharmacological strategies.
Chair of Mentorship Committee
Alpana Shukla, MD, MRCP, FTOS
Dr Alpana Shukla MD, MRCP(UK) is an Associate Professor of Research in Medicine at Weill Cornell Medical College and an Associate Attending Physician at New-York Presbyterian Hospital.
Dr Shukla obtained her medical degrees, MBBS and MD from Grant Medical College & J J Group of Hospitals in Mumbai, India. She subsequently trained in the UK as a senior house officer in Medicine, Specialist Registrar and Clinical Fellow in Endocrinology and as Registrar in Clinical Pharmacology in Australia over the next 5 years. While in the UK, she completed the training and examination requirements and was granted the MRCP(UK) degree.
Dr. Shukla is currently the Director of Clinical Research at the Comprehensive Weight Control Center and has mentored numerous graduate students, medical students, and residents in their obesity and metabolic disease research endeavors. A key area of Dr. Shukla’s research is a novel behavioral intervention, termed “food order,” for regulation of blood glucose in individuals with overweight/obesity, type 2 diabetes, and prediabetes.
Board of Directors